Introduction
Natural Killer (NK) cells represent a lymphocyte population capable of recognizing and lysing tumor cells and virus-infected cells in the absence of previous sensitization 1, 2 . NK cell function is regulated by a balance between activating and inhibitory signals. Upon specific recognition of HLA-class I molecules, the HLAclass I specific inhibitory receptors suppress NK cell cytolytic activity while target cell lysis will require a partial or complete downregulation of HLA-class I molecules [3] [4] [5] [6] [7] .
Several structurally different activating receptors are involved in NK cell-mediated cytotoxicity. The CD16 receptor, expressed on the majority of peripheral blood NK cells, mediates antibody-dependent cytotoxicity (ADCC) against IgG-coated target cells. CD16 associates with CD3ζ and FcεRγ which carry cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAM) 8 . NK-mediated lysis of tumor or virus-infected cells is mainly mediated by NKp46, NKp30 and NKp44, collectively referred to as "Natural Cytotoxicity Receptors" (NCR) and by NKG2D 5, [9] [10] [11] . NKp46 and NKp30, are present on both resting and activated NK cells, while
NKp44 is expressed only upon NK cell activation. NKp30 and NKp46 deliver intracellular signals thanks to their association with CD3ζ or CD3ζ plus FcεRγ respectively, while NKp44 associates with the KARAP/DAP12 molecules 12 .
Other activating receptors include DNAM-1, 2B4, NTBA and NKp80. Notably, 2B4, NTBA and NKp80 are considered co-receptors as they can significantly increase the NK cell cytotoxicity against some cellular targets when they are co-ingaged with NCR or NKG2D [13] [14] [15] [16] [17] .
It is evident that the surface expression of activating receptors is crucial for the NKmediated killing of various target cells. Therefore, it appeared conceivable that immunosuppressive drugs such as glucocorticoids (GC) could impair the NK cell function by affecting the surface expression and/or the function of activating NK receptors. In this context, we have recently shown that pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), display a profound downregulation of most activating NK receptors and co-receptors and an impaired cytolytic activity. This effect appeared to be related to the administration of methylprednisolone (MePDN) to treat Graft versus Host Disease (GvHD). Indeed, in
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From vitro analysis of NK cells from normal donors confirmed that MePDN could induce both downregulation of the NKp30 and NKG2D activating NK receptors and a sharp impairment of NK cell function. Moreover, in spite of its unaltered surface expression, NKp46 failed to efficiently transduce triggering signals 18 .
In this context, however, it should be stressed that NK cell cytotoxicity is a complex process that requires adhesion to target cells, synapse formation, signal trasduction leading to granule polarization and exocytosis. Accordingly, it is conceivable that MePDN might also interfere with different steps of this process.
In previous studies, GCs have been shown to inhibit different T cell functional activities (including proliferation, cytotoxicity, and cytokine production) mostly by interfering with the IL-2-induced JAK-STAT signaling pathway and with the transactivation of other transcription factors such as NF-kB and Activated Protein-1 (AP-1) [19] [20] [21] [22] [23] . These effects appear to be mainly mediated by GCs-induced leucine zipper (GILZ) and the MAPK phosphatase-1 (MKP-1). Remarkably, their expression is positevely regulated by GCs. Both proteins have been shown to interfere with NFkB-and AP-1-mediated transcription and to inhibit both MAPK kinase activity and ERK-mediated signaling 19, [24] [25] [26] [27] . It is of note that ERK activation is required for lymphocyte proliferation and is involved in lymphocyte-mediated cytotoxicity through the induction of granule exocytosis [28] [29] [30] .
In order to extend our previous finding that MePDN exerts an inhibitory effect on NK cell function, we analyzed the effect of MePDN treatment on NK cells cultured in the presence not only of IL-2 but also of IL-15, a cytokine that plays a major role in the NK cell development in vivo, as well as in NK cell activation and proliferation [31] [32] [33] [34] .
We show that IL-2-cultured NK cells display a higher susceptibility to apoptotic cell death and to inhibition of cell proliferation as compared to NK cells cultured in IL-15. 
Methods
Approval was obtained for these studies from the institutional review boards of the Istituto Nazionale per la Ricerca sul Cancro (IST) and the Ospedale San Martino, Genova. Informed consent was provided according to the Declaration of Helsinki.
Cell cultures
Peripheral mononucleated cells (PBMC) were collected from peripheral blood of healthy donors and isolated by centrifugation on density gradient (Lympholyte, Cedarlane Lab., Hornby, Ontario Canada) as previously described 35 .
NK cells were purified from whole blood by negative selection with Rosette-Sep NK (200 U/ml; 100 U/ml; 20 U/ml) or IL-15 (50 ng/ml; 25 ng/ml ; 5 ng/ml corresponding to 100U/ml; 50U/ml and 10U/ml respectively) in the presence or in the absence of MePDN (0.5 µg/ml).
MAbs and cytofluorimetric analysis.
The following mAbs were produced in our laboratory: JT3a (anti-CD3 IgG2a), KD1
(anti-CD16 IgG2a), c218 (anti-CD56, IgG1) and the following mAbs were kindly provided by D. Pende or A. Moretta: GPR165 (anti-CD56, IgG2a), 7A6 (anti-NKp30
IgG1), BAT-221 (anti-NKG2D, IgG1), BAB 281 (anti-NKp46, IgG1), PP35 (anti-2B4, IgG1) and F22 (anti-DNAM, IgG1) 5, 36 . Cytofluorimetric analysis were Lysates were analyzed on a 7.5% SDS-polyacrylamide gel, and the proteins were transferred to Immobilon polyvinylidene difluoride membranes (Millipore, Bedford, MA). Membranes were blocked with 4% bovine serum albumin in Tris-buffered saline containing 0.1% Tween-20 (TBST) overnight, and western blot analysis was performed as previously described 38 followed by detection using enhanced chemiluminescence system (Amersham Pharmacia Biotech) according to the manufacturer's instructions. 
MePDN interferes with IL-2/15 signaling pathway by inhibiting STAT1, STAT3
STAT5 and JAK3 Tyr-phosphorylation.
We next investigated whether the IL-2 and IL-15 signal trasduction pathways were differently affected by corticosteroid treatment. Since CD122 and CD132 subunits are common for IL-2 and IL-15 receptor complexes, the signal trasduction pathways involved are shared as well 39 . CD132 is known to bind JAK-3, wich activates STAT5, while CD122 displays tyrosine sites that bind JAK-1 which, in turn, activates STAT3 39, 40 . Recent data revealed that also STAT1 becomes phosphorylated upon IL-2-receptor crosslinking 41 . Thus, we analyzed Tyr-phosphorylation of STAT1, Since lytic granule exocytosis depends on the phosphorylation of ERK 1/2 molecules, we focused our studies also on the IL-2-or IL-15-mediated activation of ERK1/2.
Western blot analyses were performed on NK cells treated overnight as described above. Figure 3 , panel B, shows a representative experiment out of 6 performed: it is evident that MePDN concentrations (1 µg/ml and 0,5 µg/ml) that were inhibitory on STATs phosphorylation (see Fig.2 ), also inhibited ERK1/2 phosphorylation primarily in NK cells cultured in IL-2.
MePDN treatment inhibits NK receptor-mediated cytotoxicity and ERK phosphorylation both in the presence of IL-2 and IL-15.
In a previous study, we showed that the inhibitory effect of MePDN on the cytolytic activity of IL-2-cultured NK cells was due, at least in part, to the impairment of the NK receptor-mediated signaling as revealed by mAb-mediated redirected killing assays 18 . Thus, we analyzed whether MePDN exerted a similar effect also on IL-15-cultured NK cells. We performed redirected killing assays using the FcγR + P815 cell line as target cells. This would allow us to assess whether those activating NK receptors that were not modulated by steroid treatment, could transduce an efficient signal upon mAb-mediated crosslinking. might, in some individuals, "rescue" the NKp46-mediated natural cytotoxicity. It is of note that CD16 and NKp46 share the signaling pathway via the same ITAM bearing molecules. It has been suggested that differences in aminoacid charged residues in the transmembrane region may be, at least in part, responsible for differences in CD16-and NKp46-mediated activation, as we observed in the presence of IL-2 57 .
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Regarding the inhibitory effect on ERK phosphorylation, it has been reported that GCs interfere with the MAPK signaling pathways resulting in reduced ERK activation 19 . Our results suggest that GCs interfere with ERK phosphorylation in NK cells with a mechanism that selectively inhibits molecules that are crucial for natural cytotoxicity but not for ADCC. In this context, the calcium signal and degranulation mediator PLCγ2 could represent a likely candidate 58, 59 .
During the process of cell-mediated cytotoxicity, a correct assembly of the immunological synapse (IS) with clustering of lipid rafts and recruitment of protein kinases is crucial for signal transduction 60, 61 . Panel B -The activating NK receptors analyzed above (Fig 5, panel A) were also tested for their ability to induce cytotoxicity in a redirected killing assay using the 
